Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Steffel

Showing results (11-20 of 204) with videos related to

Pageof 21
Sort By:
Pacing and Clinical Electrophysiology : PACE|June 12, 2013
An unusual reason for loss of biventricular pacingJan Steffel, David Hürlimann
Praxis|July 6, 2017
Alexander Breitenstein, Jan Steffel
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 22, 2015
Magnetic field interaction between a left ventricular assist device controller and a cardiac resynchronization therapy-defibrillatorMartin Meyer, Jan Steffel
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 22, 2021
Dose adjustment based on the plasma level measurement used anti-FXa chromogenic assay on the use of non-vitamin K antagonist oral anticoagulants (NOACs) improved the overall benefit of NOACs dosing in patients with atrial fibrillation: Authors' replyJan Steffel, Hein Heidbüchel
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 4, 2021
2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: comment-Authors' replyJan Steffel, Hein Heidbüchel
European Heart Journal|April 25, 2018
'Ten Commandments' of the EHRA Guide for the Use of NOACs in AFJan Steffel, Hein Heidbuchel
European Heart Journal|September 19, 2013
Mechanical dyssynchrony in CRT: still searching for the Holy GrailJan Steffel, Christophe Leclercq
European Heart Journal|August 31, 2012
Apixaban in renal insufficiency: successful navigation between the Scylla and CharybdisJan Steffel, Gerhard Hindricks
European Heart Journal|March 23, 2011
Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolismJan Steffel, Eugene Braunwald
European Heart Journal|September 21, 2019
Strategies in patients with atrial fibrillation taking non-vitamin K antagonist oral anticoagulants (NOACs) and co-medications with possible drug-drug interactionTatjana Potpara, Jan Steffel
Pageof 21

Showing results (11-20 of 204) with videos related to

Sort By:
Pageof 21
Pacing and Clinical Electrophysiology : PACE|June 12, 2013
An unusual reason for loss of biventricular pacingJan Steffel, David Hürlimann
Praxis|July 6, 2017
Alexander Breitenstein, Jan Steffel
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 22, 2015
Magnetic field interaction between a left ventricular assist device controller and a cardiac resynchronization therapy-defibrillatorMartin Meyer, Jan Steffel
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 22, 2021
Dose adjustment based on the plasma level measurement used anti-FXa chromogenic assay on the use of non-vitamin K antagonist oral anticoagulants (NOACs) improved the overall benefit of NOACs dosing in patients with atrial fibrillation: Authors' replyJan Steffel, Hein Heidbüchel
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 4, 2021
2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: comment-Authors' replyJan Steffel, Hein Heidbüchel
European Heart Journal|April 25, 2018
'Ten Commandments' of the EHRA Guide for the Use of NOACs in AFJan Steffel, Hein Heidbuchel
European Heart Journal|September 19, 2013
Mechanical dyssynchrony in CRT: still searching for the Holy GrailJan Steffel, Christophe Leclercq
European Heart Journal|August 31, 2012
Apixaban in renal insufficiency: successful navigation between the Scylla and CharybdisJan Steffel, Gerhard Hindricks
European Heart Journal|March 23, 2011
Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolismJan Steffel, Eugene Braunwald
European Heart Journal|September 21, 2019
Strategies in patients with atrial fibrillation taking non-vitamin K antagonist oral anticoagulants (NOACs) and co-medications with possible drug-drug interactionTatjana Potpara, Jan Steffel
Pageof 21